Polar Asset Management Partners’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-4,104
Closed -$1.87M 672
2025
Q3
$1.87M Sell
4,104
-5,496
-57% -$2.24M 0.04% 397
2025
Q2
$3.13M Buy
+9,600
New +$2.66M 0.08% 261
2024
Q4
Sell
-5,900
Closed -$1.62M 670
2024
Q3
$1.62M Sell
5,900
-4,100
-41% -$1.07M 0.04% 361
2024
Q2
$2.43M Sell
10,000
-12,600
-56% -$1.99M 0.06% 293
2024
Q1
$3.38M Buy
+22,600
New +$3.77M 0.09% 277
2022
Q4
Sell
-19,600
Closed -$3.92M 1241
2022
Q3
$3.92M Buy
+19,600
New +$3.74M 0.05% 564

Other funds holding ALNY